XML 71 R59.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
May 24, 2018
Apr. 10, 2018
Apr. 02, 2018
Jan. 04, 2018
Jun. 08, 2017
Jan. 31, 2018
May 31, 2017
Dec. 31, 2016
Dec. 31, 2012
Sep. 30, 2018
Dec. 31, 2017
Compensation commitments                     $ 400,000
NIS [Member]                      
Monthly consultation fee       $ 40,000              
CardioSert Ltd [Member]                      
Initial payment   $ 250,000   $ 50,000              
Number of common shares acquired 6,738 6,738                  
Number of common shares acquired, value   $ 74,000                  
Buy back amount per patent       $ 1.00              
CardioSert Ltd [Member] | Before Reverse Split [Member]                      
Number of common shares acquired 100,000 100,000                  
Former Executive [Member]                      
Compensation commitments                   $ 400,000  
Car Lease Agreements [Member]                      
Lease term               Dec. 31, 2019      
Monthly lease payment               $ 2,500      
Officer Lease Agreement [Member]                      
Lease term           Dec. 31, 2021 Dec. 31, 2020        
Monthly lease payment           $ 4,000 $ 14,000        
Securities Purchase Agreement [Member]                      
Purchase price of Plaintiffs         $ 3,375,000            
Loss contingency, damages sought         $ 1,000,000            
Minimum [Member] | CardioSert Ltd [Member]                      
Investments       $ 2,000,000              
Technician Research And Development Foundation Limited [Member] | Minimum [Member]                      
Royalties payable as percentage of future sales                 1.50%    
Technician Research And Development Foundation Limited [Member] | Maximum [Member]                      
Royalties payable as percentage of future sales                 3.00%    
Vice President of R&D [Member] | 2017 Equity Incentive Plan [Member]                      
Number of options to purchase common stock     10,000                
Vice President of R&D [Member] | Before Reverse Split [Member] | 2017 Equity Incentive Plan [Member]                      
Number of options to purchase common stock     150,000                
Israeli Innovation Authority [Member] | 2013 Through September 30, 2018 [Member]                      
Total grants obtained                   $ 1,310,000  
Royalties payable as percentage of future sales                   3.00%